{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-024228","form_type":"8-K","ticker":"XTNT","cik":"0001453593","company_name":"Xtant Medical Holdings, Inc.","filed_at":"2023-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.981349+00:00","generated_at":"2026-06-13T09:57:22.533687+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Xtant Medical extends deadline to terminate Surgalign asset purchase agreement to July 20, 2023","bullets":["First Amendment extends Xtant's termination right deadline from July 10 to July 20, 2023 for reviewing disclosure schedules.","Amends mutual release provisions in the original Asset Purchase Agreement to clarify scope.","Original deal: Xtant pays $5M cash for hardware/biologics assets of Surgalign in Chapter 11.","Xtant is stalking horse bidder; auction may result in higher or better offers."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-024228","json":"https://secwatch.observer/filing/0001493152-23-024228.json","markdown":"https://secwatch.observer/filing/0001493152-23-024228.md","text":"https://secwatch.observer/filing/0001493152-23-024228.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453593/000149315223024228/0001493152-23-024228-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453593/000149315223024228/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T09:57:22.533687+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9df7a3f2d9563540092827358b7c86f51b10356c","claim":"Xtant Medical Holdings, Inc. amended Asset Purchase Agreement with Surgalign Holdings, Inc. valued at $5 million in cash (effective 2023-07-10).","evidence_excerpt":"On July 10, 2023, the Company and the Seller entered into a First Amendment to Asset Purchase Agreement (the “Amendment”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1453593/000149315223024228/0001493152-23-024228-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Surgalign Holdings, Inc."},{"label":"Value","value":"$5 million in cash"},{"label":"Effective","value":"2023-07-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}